TipRanks
Go Ultimate55% OFF

Kiniksa Pharmaceuticals (KNSA) Cash flow

Kiniksa Pharmaceuticals Cash Flow

KNSA's free cash flow for Q3 2026 was $47.10M. For the 2026 fiscal year, KNSA's free cash flow was decreased by $-180.00K and operating cash flow was $47.28M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ 25.69M$ 25.69M$ 13.30M$ 5.81M$ -126.30M
$ 37.67M$ 37.67M$ -29.56M$ -8.08M$ 128.63M
$ 12.27M$ 12.27M$ 1.50M$ 2.52M$ 5.88M
$ 183.58M$ 183.58M$ 107.95M$ 122.72M$ 122.47M
$ 25.41M$ 25.41M$ 13.17M$ 5.70M$ -146.71M

Currency in USD

Kiniksa Pharmaceuticals Cash Flow

-400M-200M0200M400M201720182019202020212022202320242025OperatingInvestingFinancing